Sponsor:
Children's Oncology Group
Code:
NCT04870944
Conditions
Diffuse Midline Glioma, H3 K27-Altered
Metastatic Malignant Neoplasm in the Central Nervous System
Recurrent Diffuse Intrinsic Pontine Glioma
Recurrent Diffuse Midline Glioma, H3 K27-Altered
Recurrent Lymphoma
Eligibility Criteria
Sex: All
Age: 1 - 21
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Bone Marrow Aspirate
Bone Marrow Biopsy
Echocardiography Test
FACT Complex-targeting Curaxin CBL0137
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-20. This information was provided to ClinicalTrials.gov by Children's Oncology Group on 2026-02-24.